Le Business: Life Sciences Abroad, Why Boston?

November 15, 2018

Joint Event

Thursday, November 15, 2018 From 7:00 PM To 9:00 PM

At The French Cultural Center Get Directions 

For the second event in our special business series, we will compare the French and American healthcare systems and how they define research and investments in the biomedical environment. This round table will also explore if France can adapt to an era of customized medical treatments and why so many French pharmaceutical groups elect Boston as their American headquarters.

 

Moderated by Jennifer Schunemann, President of JCS Consulting and Founder and Past President of The Goodwin Group International.

Co-presented with the French Cultural Center. 

Students, Jeunes Ambassadeurs, VIEs: $5
Members: $10
General Admission: $20

*The FACC-NE operates on a policy of advance registration and payment. Registrations are collected on a first-come basis and
must be guaranteed with a credit or debit card at the time of booking. RSVPs are transferable. There will be no refunds for
cancellations 48 hours before an event or no shows.

About the Moderator

 

Jennifer Schünemann is a publisher, mentor, and proven, successful entrepreneur in the world of international medical publishing. At 32 she started her first company, and in 2014 sold The Goodwin Group International to the world’s 5th largest journals publisher, SAGE Publications Inc. At the time of sale, Ms. Schünemann’s hallmark publication, MD Conference Express, reached more than 1 million medical practitioners in more than 95 countries, in 16 languages. Upon joining SAGE, Ms. Schünemann was appointed to the Senior Management Group, tasked with leading the 1500+ employee organization with principal offices in Boston, Los Angeles, London, New Delhi, Singapore, and Washington, D.C. In 2016 she founded the New England chapter of Durga Tree International, a global charity that fights human trafficking, and in 2017, she was appointed to the Board of Directors of the Umbrella Community Arts Center.

Ms. Schünemann speaks four languages and has traveled to 52 countries. She holds a dual Bachelor of Arts Degree from the University of Pennsylvania, and has studied and lived abroad in Paris, France where she took courses at the Paris Institute of Political Studies (Sciences Po). She is a Chairman Circle member of the French Heritage Society, and a member of the American Friends of Lafayette.


About the Panelists

Stephane Kowalczuk is a seasoned financial controller with broad global and functional leadership experience in the bio-pharma industry.

Over the last 15 years, Stephane has developed a strong expertise in R&D portfolio funding and prioritization, OPEX optimization, Business solutions design and implementation. Stephane relocated from the Netherlands to Boston in 2013 and is currently the Head of Finance for Medical Affairs at Sanofi-Genzyme.

Thomas Marchand is a 35 years old French entrepreneur living in Boston, who co-founded BIOMODEX in 2015 after a successful exit in the service industry.

He has been elected the French-American entrepreneur of the Year 2016 and is regularly invited at the Babson College (#1 ranked entrepreneurship MBA) as a guest for the Entrepreneurial finance program.

Thomas is committed to providing new tools to physicians to better prepare and rehearse surgical procedures in order to improve clinical outcomes.

Aude Ouensanga is a Manager at Alira Health. She joined the company’s Paris office in 2012 and its Boston office in 2015. Aude managed dozens of market access, commercial due diligence, corporate strategy and M&A projects for US, EU and Japan based clients in MedTech and Pharma. She advised both start-ups and multi billions corporations in their business development. Prior to joining Alira Health, Aude had been a M&A Analyst at BNP Paribas Corporate & Investment Banking for the chemicals sector and a Strategy Analyst at Novartis Pharma. Aude holds a degree from French Grande Ecole EM Lyon Business School where she specialized in Finance and Strategy and is a registered investment banker in the US, holding FINRA Series 79 and 63 certifications.

Calendar of events

< December 2018 >
Mon.Tue.Wed.Thu.Fri.Sat.Sun.
1
2
3
4
5
6 7 8
9
10
11
12
13 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

They Support FACCNE

    • AMA XpertEye
    • Albany Engineered
    • Alira Health
    • Amadeus
    • Axelia Partners (former Marie Landel & Associates)
    • Be Relax
    • BioMerieux
    • Boston Accueil
    • Boston Strasbourg Sister City Association
    • Cisbio
    • DSML Executive Search
    • Dassault Systems
    • Edenred
    • Esco Tool
    • Essilor
    • French Cultural Center
    • French Tech Hub
    • GuesttoGuest
    • Hepatochem
    • IAdvize
    • IdeaPaint
    • Ipsen
    • Keolis CS
    • LAZ Parking
    • LogicBio Therapeutics
    • MGB US Inc.
    • MS Walker
    • Magicforest
    • Mc Dermott Will & Emery
    • Merieux Developpement
    • Miltons Distributing
    • Mirakl
    • Moderna Therapeutics
    • NFI
    • Nanobiotix
    • Nokia
    • North Shore InnoVentures
    • OpenDataSoft
    • Pact and Partners
    • PathMaker NeuroSystems
    • Paul Frank + Collins P.C.
    • Puma
    • SES America
    • Sanofi Genzyme
    • Saul Ewing Arnstein & Lehr
    • Schneider Electric
    • Sky Handling Partner
    • Socomec
    • Softbank Robotics
    • Spring Technologies
    • Valti
    • Veolia
    • Vivra
    • World Boston

185 Alewife Brook Parkway, Suite 200 
Cambridge, MA 02138
 T: (617) 520-2121 
 contact(at)faccne.org

Please contact us to schedule an appointment.

 

 

© 2018 FACC NEW ENGLAND